*Казачьи чины*

via forma full 5 https://ift.tt/7AVItLU Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3575348.html)

Казачьи чины

via forma full 5 https://ift.tt/7AVItLU Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Классификация*

via forma full 5 https://ift.tt/VSH3oUC Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3578411.html)

Классификация

via forma full 5 https://ift.tt/VSH3oUC Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*ГОСТ Р*

via forma full 5 https://ift.tt/rixIDYF Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3577485.html)

ГОСТ Р

via forma full 5 https://ift.tt/rixIDYF Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*PROFARMY =?UTF-8?B?0JrRg9C/0LjRgtGMIC0g0KTQvtGA0LzQsCDQvtC00LXQttC00Ys=?=*

Компания PROFARMY является динамично развивающейся организацией в сфере военного обмундирования и снаряжения вот уже более 9 лет.via forma full 5 https://ift.tt/VWphYAB Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3579505.html)

PROFARMY =?UTF-8?B?0JrRg9C/0LjRgtGMIC0g0KTQvtGA0LzQsCDQvtC00LXQttC00Ys=?=

Компания PROFARMY является динамично развивающейся организацией в сфере военного обмундирования и снаряжения вот уже более 9 лет.via forma full 5 https://ift.tt/VWphYAB Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Cathie Wood snaps up nearly 4 million shares of a surging biotech stock*

Ark Invest's "disruptive" technology thesis grants investors exposure to a number of different technological areas, from automation to cryptocurrency to biotechnology. While automation and crypto represent some of Ark's biggest bets, a large portion even of Ark's flagship Innovation fund consists of biotechnology companies working to revolutionize the health sector. Ark on Tuesday heavily boosted its stake in one such company, buying 3,750,623 shares of Recursion Pharmaceuticals RXRX, a purchase worth roughly $24 million. This latest purchase boosted Ark Innovation's holding in Recursion to 3,980,912 shares, worth $25.7 million and weighted at only .35% of the ETF. Related: Cathie Wood explains why she cut Ark's Tesla holding The stock closed up 10.8% Tuesday, rising a further 2.9% in pre-market trading. Recursion's stock, however, remains far off its July 52-week high of $16.75, when the biotech firm announced a partnership with semiconductor giant Nvidia NVDA. The collaboration, which came in hand with a $50 million investment by Nvidia in Recursion, is meant to help the latter revolutionize drug discovery through artificial intelligence, the company said in a statement. Shares of Recursion have fallen hard off those mid-summer highs, hitting a low of around $5 in early November before rising again. Reporting third-quarter results Nov. 9, Recursion noted revenue of $10.5 million for the quarter, a decline from the $13.2 million the company earned in the year-ago period. Recursion also reported greater expenses and a wider net loss of $93 million for the quarter, above the $60.4 million the company reported for the same period last year. Related: Cathie Wood sells 250,000 shares of a rising growth stock Recursion had $387.3 million in cash as of Sept. 30, a reduction from prior quarters. The results fell short of Street expectations. "We could not be more inspired about the future and are confident that the Recursion OS will continue to lead the transformation of BioTech into TechBio," CEO Chris Gibson said in a statement. The company reiterated in its earnings report several enhanced partnerships with the likes of Bayer and Roche-Genentech, both of which are meant to enhance its different programs and experiments. Recursion's approach has resulted in the development of several potential candidates, but none have escaped clinical trials so far. Shares of Recursion, closing Tuesday at $6.46, are down roughly 16% for the year. Related: Cathie Wood has a blunt warning for the future of Google's stock Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/cathie-wood-ark-invest-stocks-biotech)

Cathie Wood snaps up nearly 4 million shares of a surging biotech stock

Ark Invest's "disruptive" technology thesis grants investors exposure to a number of different technological areas, from automation to cryptocurrency to biotechnology. While automation and crypto represent some of Ark's biggest bets, a large portion even of Ark's flagship Innovation fund consists of biotechnology companies working to revolutionize the health sector. Ark on Tuesday heavily boosted its stake in one such company, buying 3,750,623 shares of Recursion Pharmaceuticals RXRX, a purchase worth roughly $24 million. This latest purchase boosted Ark Innovation's holding in Recursion to 3,980,912 shares, worth $25.7 million and weighted at only .35% of the ETF. Related: Cathie Wood explains why she cut Ark's Tesla holding The stock closed up 10.8% Tuesday, rising a further 2.9% in pre-market trading. Recursion's stock, however, remains far off its July 52-week high of $16.75, when the biotech firm announced a partnership with semiconductor giant Nvidia NVDA. The collaboration, which came in hand with a $50 million investment by Nvidia in Recursion, is meant to help the latter revolutionize drug discovery through artificial intelligence, the company said in a statement. Shares of Recursion have fallen hard off those mid-summer highs, hitting a low of around $5 in early November before rising again. Reporting third-quarter results Nov. 9, Recursion noted revenue of $10.5 million for the quarter, a decline from the $13.2 million the company earned in the year-ago period. Recursion also reported greater expenses and a wider net loss of $93 million for the quarter, above the $60.4 million the company reported for the same period last year. Related: Cathie Wood sells 250,000 shares of a rising growth stock Recursion had $387.3 million in cash as of Sept. 30, a reduction from prior quarters. The results fell short of Street expectations. "We could not be more inspired about the future and are confident that the Recursion OS will continue to lead the transformation of BioTech into TechBio," CEO Chris Gibson said in a statement. The company reiterated in its earnings report several enhanced partnerships with the likes of Bayer and Roche-Genentech, both of which are meant to enhance its different programs and experiments. Recursion's approach has resulted in the development of several potential candidates, but none have escaped clinical trials so far. Shares of Recursion, closing Tuesday at $6.46, are down roughly 16% for the year. Related: Cathie Wood has a blunt warning for the future of Google's stock Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...

*Тактические брюки*

via forma full 5 https://ift.tt/28vQVAF Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3578067.html)

Тактические брюки

via forma full 5 https://ift.tt/28vQVAF Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*What song?*

submitted by /u/Ch1canery to r/musicsuggestions [link] [comments]
[Read more...](https://www.reddit.com/r/musicsuggestions/comments/17v4ptu/what_song/)

What song?

submitted by /u/Ch1canery to r/musicsuggestions link comments
Read more...

*My brother's new cover-up and in honor tattoos*

My 25yo brother got his ex-girlfriend's and her kid's (from another relationship) initials tattooed on his forearms. They dated for 2 months before they broke up. He decided to get the tree of life with a cross coming out of it to cover her initials. He has yet to cover the kid's. He is now is dating a new girl. They've been dating close to a month now and he decided to get the Star of David in honor of her being Jewish. Let's see how long this one lasts
[Read more...](https://www.reddit.com/r/shittytattoos/comments/17v7n4a/my_brothers_new_coverup_and_in_honor_tattoos/)

My brother's new cover-up and in honor tattoos

My 25yo brother got his ex-girlfriend's and her kid's (from another relationship) initials tattooed on his forearms. They dated for 2 months before they broke up. He decided to get the tree of life with a cross coming out of it to cover her initials. He has yet to cover the kid's. He is now is dating a new girl. They've been dating close to a month now and he decided to get the Star of David in honor of her being Jewish. Let's see how long this one lasts
Read more...

*What would the first on your playlist?*

submitted by /u/Garrod_Ran to r/starwarsmemes [link] [comments]
[Read more...](https://www.reddit.com/r/starwarsmemes/comments/17vl014/what_would_the_first_on_your_playlist/)

*Old yet gold.*

submitted by /u/anthr_bihari to r/SipsTea [link] [comments]
[Read more...](https://www.reddit.com/r/SipsTea/comments/17vnc33/old_yet_gold/)

*2meirl4meirl*

submitted by /u/nlundq to r/2meirl4meirl [link] [comments]
[Read more...](https://www.reddit.com/r/2meirl4meirl/comments/17vofb5/2meirl4meirl/)

2meirl4meirl

submitted by /u/nlundq to r/2meirl4meirl link comments
Read more...